Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. [electronic resource]
Producer: 19990702Description: 273-7 p. digitalISSN:- 0141-9838
- Animals
- Antiprotozoal Agents -- therapeutic use
- Cyclooxygenase Inhibitors -- therapeutic use
- Disease Progression
- Female
- Immunity, Cellular
- Indomethacin -- therapeutic use
- Leishmania major
- Leishmaniasis, Cutaneous -- drug therapy
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Prostaglandin Antagonists -- therapeutic use
- Th1 Cells -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.